Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20989331 | 0.78 | MAPT (0.32) | KDM4EALDH1A1 | |
| SCHEMBL22498133 | 0.72 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL3663785 | 0.72 | — | — | |
| SCHEMBL2562394 | 0.71 | — | — | |
| SCHEMBL7789990 | 0.69 | MAPK1 (0.30) | — | |
| SCHEMBL8686925 | 0.67 | OPRL1 (0.30) | — | |
| SCHEMBL19708267 | 0.67 | — | — | |
| SCHEMBL8685924 | 0.67 | OPRL1 (0.30) | — | |
| SCHEMBL8775050 | 0.66 | — | — | |
| SCHEMBL1802734 | 0.65 | DAO (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190256451-A1 | DISCRIMINATION OF CIS- AND TRANS-1,3-DIAMINOCYCLOHEXANES | BASF SE (DE) | 2019-08-22 | — | — | US | disclosed |
| US-20190126194-A1 | CYCLOHEXANEDIAMINES FOR USE IN GAS SCRUBBING | BASF SE (DE) | 2019-05-02 | — | — | US | disclosed |
| EP-3468945-A1 | DISCRIMINATION OF CIS- AND TRANS-1, 3-DIAMINOCYCLOHEXANES | BASF SE (DE) | 2019-04-17 | — | — | EP | disclosed |
| EP-3468692-A1 | CYCLOHEXANDIAMINES FOR USE IN GAS SCRUBBING | BASF SE (DE) | 2019-04-17 | — | — | EP | disclosed |
| WO-2017211935-A1 | DISCRIMINATION OF CIS- AND TRANS-1, 3-DIAMINOCYCLOHEXANES | BASF SE (DE) | 2017-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190256451-A1 | DISCRIMINATION OF CIS- AND TRANS-1,3-DIAMINOCYCLOHEXANES | SAT1, AOC1, CPS1 | KDM4E 4057/4885ALDH1A1 1235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.